BioLife Solutions - 26 Year Stock Price History | BLFS

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for BioLife Solutions as of October 19, 2018 is 12.41.
BioLife Solutions Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 11.6337 5.9600 25.4750 4.7330 12.4100 106.83%
2017 3.5120 1.6200 6.9000 1.6200 6.0000 272.60%
2016 1.7638 2.0500 2.3700 1.4500 1.6103 -25.79%
2015 2.0760 1.6400 2.7900 1.5000 2.1700 32.32%
2014 3.4332 8.4000 8.4000 1.6400 1.6400 -80.48%
2013 7.2089 4.7600 19.6000 3.5000 8.4000 76.47%
2012 2.0098 0.7000 6.3000 0.5600 4.7600 580.00%
2011 1.0228 1.2600 1.5400 0.2800 0.7000 -16.67%
2010 1.0978 1.5400 1.8200 0.5600 0.8400 -45.45%
2009 1.5167 0.5600 2.9400 0.4200 1.5400 266.67%
2008 0.7747 0.8400 1.2600 0.2800 0.4200 -50.00%
2007 1.4162 1.1200 2.3800 0.7000 0.8400 -14.29%
2006 1.1579 1.6800 1.6800 0.8400 0.9800 -41.67%
2005 1.7006 0.8400 3.5000 0.8400 1.6800 33.33%
2004 1.9344 1.5400 3.3600 0.9800 1.2600 -18.18%
2003 1.7944 1.6800 3.0800 1.1200 1.5400 -8.33%
2002 2.1189 2.8000 4.0600 1.2600 1.6800 -42.86%
2001 4.3767 7.0000 9.6600 0.7000 2.9400 -58.00%
2000 10.5867 2.6600 36.8200 2.3800 7.0000 212.50%
1999 4.9311 1.1200 12.7400 0.8400 2.2400 100.00%
1998 2.6331 3.0800 6.5800 0.8400 1.1200 -57.89%
1997 5.6028 4.7600 10.0800 2.2400 2.6600 -44.12%
1996 25.2937 31.5000 46.3400 3.9200 4.7600 -83.00%
1995 40.5606 42.0000 51.6600 28.0000 28.0000 -33.33%
1994 44.1133 56.0000 65.6600 26.3200 42.0000 -25.00%
1993 81.1618 119.0000 119.0000 43.8200 56.0000 -54.29%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.204B $0.011B
BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.867B 19.45
Abbott Laboratories (ABT) United States $118.574B 24.05
Stryker (SYK) United States $63.182B 24.41
Boston Scientific (BSX) United States $50.532B 26.29
Baxter (BAX) United States $37.110B 25.26
Zimmer Biomet Holdings (ZBH) United States $25.314B 16.26
ResMed (RMD) United States $14.694B 29.17
Smith & Nephew SNATS (SNN) United Kingdom $14.608B 0.00
Canopy Growth (CGC) Canada $10.780B 0.00
Perrigo (PRGO) Ireland $9.837B 13.96
Bio-Rad Laboratories (BIO) United States $8.382B 53.82
Hill-Rom Holdings (HRC) United States $5.797B 19.66
Haemonetics (HAE) United States $5.495B 50.15
ICU Medical (ICUI) United States $5.418B 36.71
Insulet (PODD) United States $5.203B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.301B 0.00
Hutchison China MediTech (HCM) China $4.012B 0.00
Agios Pharmaceuticals (AGIO) United States $3.879B 0.00
Neogen (NEOG) United States $3.281B 49.69
NuVasive (NUVA) United States $3.191B 30.27
National Vision Holdings (EYE) United States $3.137B 69.28
Quidel (QDEL) United States $2.525B 51.73
NxStage Medical (NXTM) United States $1.815B 0.00
Phibro Animal Health (PAHC) United States $1.784B 25.40
Cardiovascular Systems (CSII) United States $1.263B 727.80
AtriCure (ATRC) United States $1.071B 0.00
VAREX IMAGING (VREX) United States $0.985B 16.09
Owens & Minor (OMI) United States $0.934B 9.99
OraSure Technologies (OSUR) United States $0.904B 59.08
Cerus (CERS) United States $0.887B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.874B 25.81
PetIQ (PETQ) United States $0.862B 28.18
Surmodics (SRDX) United States $0.842B 101.77
MacroGenics (MGNX) United States $0.792B 0.00
Omeros (OMER) United States $0.770B 0.00
Insys Therapeutics (INSY) United States $0.662B 0.00
Meridian Bioscience (VIVO) United States $0.660B 22.57
LeMaitre Vascular (LMAT) United States $0.542B 26.97
Lantheus Holdings (LNTH) United States $0.517B 16.07
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.445B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.323B 0.00
Cytosorbents (CTSO) United States $0.321B 0.00
Surface Oncology (SURF) United States $0.220B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
Chimerix (CMRX) United States $0.173B 0.00
Fonar (FONR) United States $0.149B 7.32
Conatus Pharmaceuticals (CNAT) United States $0.144B 0.00
Chembio Diagnostics (CEMI) United States $0.137B 0.00
United-Guardian (UG) United States $0.080B 17.61
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.31
Imprimis Pharmaceuticals (IMMY) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.057B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00